Article Text
Statistics from Altmetric.com
Key points
Guidelines on providing faecal microbiota transplants for the management of recurrent or refractory Clostridium difficile infection have been published.
Recommendations cover recipient selection and comorbidities, donor selection and screening, faecal sample collection and storage, administration of faecal microbiota transplant and follow-up.
New guidelines on faecal microbiota transplant from the British Society of Gastroenterology and Healthcare Infection Society provide recommendations to help standardise and optimise the procedure for treating recurrent Clostridium difficile infections.1
Overview
A joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) working group has developed guidelines on best practice in the provision of faecal microbiota transplant (FMT) services for people with recurrent Clostridium difficile infection (CDI).1 The guidance covers recipient selection, donor selection, clinical factors that influence transplant outcome, and practicalities of sample collection, storage and administration. In this overview, …
Footnotes
Review of Mullish BH et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2018;67:1920–41.
Contributors: DTB Team.
Provenance and peer review Commissioned; Internally peer reviewed.